Recital 10, Decision_act (EU) 2009/560

In forcesince 22 Jul 2009

In view of the epidemiological situation in the Member States concerned, it is appropriate to include the costs of the vaccine administration in the costs eligible for a financial contribution by the Community. Consequently, it is appropriate to allocate additional funds for the financing of the programmes for the eradication and monitoring of bluetongue in those Member States, approved by Decision 2008/897/EC.